MARLBOROUGH, Mass.,
July 3, 2017 /PRNewswire/ -- Hologic,
Inc. (Nasdaq: HOLX) announced today that it has notified holders of
the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No.
436440 AC5) issued March 5, 2012, and
Wilmington Trust Company, the trustee, paying agent and conversion
agent for the notes, that holders are eligible to convert the
notes. This conversion right is subject to the terms of the
base indenture governing the notes dated as of December 10, 2007, as supplemented by the third
supplemental indenture dated as of March 5,
2012 (collectively, the indenture).
The conversion right has been triggered because the closing
price of the Company's common stock exceeded approximately
$40.53, which is 130% of the
conversion price for the notes, for at least 20 of the 30
consecutive trading days ending on June
30, 2017. As a result, the notes are convertible until
September 30, 2017, subject to the
terms, conditions and adjustments in the indenture and the notes.
The notes may continue to be convertible after September 30, 2017 if one or more conditions
specified in the indenture are satisfied during future measurement
periods.
The current conversion rate for the notes is 32.07698 shares of
the Company's common stock per $1,000
principal amount outstanding, which is equivalent to a conversion
price, as defined in the indenture, of approximately $31.18 per share. The Company may elect to
satisfy its conversion obligation in shares of common stock, cash,
or a combination of cash and shares in accordance with the terms,
procedures and conditions outlined in the indenture and the
notes.
None of the Company, its board of directors, or employees has
made, or is making, any representation or recommendation to any
holder of the notes as to whether or not to exercise the conversion
right.
Holders of the notes who have questions or wish to exercise
their conversion right should contact Wilmington Trust Company
at:
Wilmington Trust Company
Rodney Square North
1100 North Market Street
Wilmington, DE 19890
Attention: Workflow Management, 5th Floor
Telephone: (302) 636-6470
A complete explanation of the conversion right, as well as the
procedures required to convert notes, is set forth in the
indenture. Holders are urged to review the conversion
procedures contained in the notes and the indenture. The base
indenture was filed as Exhibit 4.1 to the Company's Current Report
on Form 8-K filed with the Securities and Exchange Commission on
December 10, 2007. The third
supplemental indenture was filed as Exhibit 4.1 to the Company's
Current Report on Form 8-K filed with the Securities and Exchange
Commission on March 8, 2012.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women's health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com
Hologic and associated logos are trademarks and/or registered
trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.
Contact
Michael Watts
Vice President, Investor Relations and
Corporate Communications
(858) 410-8588
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hologic-delivers-notice-that-holders-of-200-convertible-exchange-senior-notes-due-2042-are-eligible-to-convert-300483016.html
SOURCE Hologic, Inc.